Medical devices company Aran Biomedical revealed on Monday the appointment of Todd Blair as vice president of its Sales and Business Development (US) to meet and manage the growing demand for its implantable biomaterial product solutions.
Effective 1 July 2020, Blair will support, identify and develop the company's new business opportunities into sustainable and long-term partnerships, lead internal teams on proposal and product solution development as well as oversee the sales and business development activities in the US marketplace with a primary focus on the Orthopaedic, General Surgery and Vascular fields.
Most recently, Blair has served as vice president of Corporate Strategy at Heraeus Medical Components.
The company said Todd brings to the new position more than 20 years of experience in sales and business development within the life sciences contract manufacturing industry, with a focus on Bio-Textiles, Nitinol devices and polymeric components.
Novo Nordisk to streamline operations and reinvest in diabetes and obesity growth
NICE endorses AOTI's TWO2 therapy for diabetic foot ulcers
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli
OptiBiotix signs distribution deal with major weight management company
GoodRx partners with Novo Nordisk to offer Ozempic and Wegovy at USD499 per month
Ocular Therapeutix secures FDA special protocol assessment for AXPAXLI NPDR trial
MetaVia collaborates with Syntekabio to explore AI-driven indications for DA-1241
Ascletis completes participant dosing in US obesity clinical study
BioLab Holdings' amnion grafts enter multicentre clinical trial